000 01262 a2200325 4500
005 20250513203115.0
264 0 _c20000303
008 200003s 0 0 eng d
022 _a0025-7125
024 7 _a10.1016/s0025-7125(05)70212-1
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBhatt, D L
245 0 0 _aAntiplatelet and anticoagulant therapy in the secondary prevention of ischemic heart disease.
_h[electronic resource]
260 _bThe Medical clinics of North America
_cJan 2000
300 _a163-79, ix p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnticoagulants
_xadministration & dosage
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aClopidogrel
650 0 4 _aCoronary Disease
_xprevention & control
650 0 4 _aHumans
650 0 4 _aMyocardial Infarction
_xprevention & control
650 0 4 _aPlatelet Aggregation Inhibitors
_xadministration & dosage
650 0 4 _aRecurrence
650 0 4 _aTiclopidine
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aTopol, E J
773 0 _tThe Medical clinics of North America
_gvol. 84
_gno. 1
_gp. 163-79, ix
856 4 0 _uhttps://doi.org/10.1016/s0025-7125(05)70212-1
_zAvailable from publisher's website
999 _c10639412
_d10639412